Biologics

The Steadman Philippon Research Institute's fourth annual Vail Scientific Summit is Aug. 19-21 in Vail, Colo., and it will focus on the clinical advances made in the study of biologics and cell therapy.

Minneapolis-based University of Minnesota researchers used 3D-printing technology to print stem cell-infused scaffolds that may be implanted in spinal cords to alleviate nerve damage, the StarTribune reports.

Co-Founder of the New York Cartilage Repair Society Eric Strauss, MD, an orthopedic surgeon with New York City-based NYU Langone Health, discusses the society and biggest trends in cartilage repair today.

The global spine biologics market is predicted to reach $2.7 billion by 2024, growing at a 4.4 percent compound annual growth rate, according to a Data Bridge Market Research report.

Researchers at Central Queensland University in Australia are developing a 3D bioprint of crocodile cartilage to promote cartilage repair, ABC Capricornia reports.

UC San Diego researchers successfully derived spinal cord neural stem cells from human pluripotent stem cells, according to research published in Nature Methods.

To meet the growing demand for alternatives to spinal fusion, Kevin Pauza, MD, certified 14 spine specialists to perform the Discseel procedure at Weill Cornell Brain and Spine Center in New York City.

The global platelet rich plasma market is projected to increase from 2018 through 2026 at a 13.3 percent compound annual growth rate, according to a Credence Research report.

Pete O'Heeron is the founder and CEO of SpinalCyte.

Aziyo Biologics will exclusively distribute its bone repair product ViBone through RTI Surgical in the U.S.